Discuss, Support, Achieve!

 

 

This page has links to information on CLOTTING DISORDERS. PSN is not endorsing these sites in any way, nor are we responsible for the content of these sites. We are just listing them for parents to find information easily.  Any and all information contained on this page should not be used to diagnose or treat any health problems, concerns or diseases.  If you have a specific medical condition or concern please contact your local health care professional.

 

 

CLOTTING DISORDERS
(Under Construction)

 

 

 

 

 

 

 

 

 

 

 

 

RESEARCH OPPORTUNITIES

Study of Abnormal Blood Clotting in Children with Stroke

This study is currently recruiting patients.

Sponsored by

National Institute of Neurological Disorders and Stroke (NINDS)

 

 

 

RESEARCH ARTICLES

Thromboplastin-thrombomodulin-mediated time: a new global test sensitive to protein S deficiency and increased levels of factors II, V, VII and X. (4/29/02)  Physician knowledge and practices in the evaluation of coagulopathies in stroke patients. (4/29/02)
Perinatal asphyxia: timing and mechanisms of injury in neonatal encephalopathy. (4/29/02) Coagulopathy as a result of factor V inhibitor after exposure to bovine topical thrombin. (4/29/02)
Possible correlation between high levels of IL-18 in the cord blood of pre-term infants and neonatal development of periventricular leukomalacia and cerebral palsy. (4/29/02) The significance of antiphospholipid antibodies in ischemic stroke in children in light of the most current studies.  (4/29/02)
High prevalence of antiphospholipid antibodies in children with epilepsy: a controlled study of 50 cases. (4/29/02) Neonatal cerebral ischaemia with elevated maternal and infant anticardiolipin antibodies.  (4/29/02)
Is thrombophilia a factor in the development of hemiplegic cerebral palsy? (4/29/02) Antiphospholipid antibody syndrome manifested as a postoperative cerebrovascular event in a child. (4/29/02)

 

 

FROM THE AMERICAN STROKE ASSOCIATION

Factor V Leiden and Antiphospholipid Antibodies Are Significant Risk Factors for Ischemic Stroke in Children (4/29/02)

Aspirin Versus Low-Dose Low-Molecular-Weight Heparin: Antithrombotic Therapy in Pediatric Ischemic Stroke Patients (4/29/02)
Activated Protein C Resistance in Ischemic Stroke Not Due to Factor V Mutation (4/29/02) Ischemic Stroke in Young Patients With Activated Protein C Resistance (4/29/02)

Therapeutic Benefit - Aspirin Revisited in Light of the Introduction of Clopidogrel (4/29/02)

Inherited Thrombophilia in Ischemic Stroke and Its Pathogenic Subtypes (4/29/02)
Hyperhomocysteinemia and Other Inherited Prothrombotic Conditions in Young Adults With a History of Ischemic Stroke (4/29/02) Prothrombotic Disorders in Children With Moyamoya Syndrome (4/29/02)

 

 

 

Back to PSN

Pediatric Stroke Network 1999-2002
All Rights Reserved.  Unauthorized use prohibited.  

The Pediatric Stroke Network copyright materials can not be copied in whole or in part by any person, organization or corporation other than PSN, it's divisions and units without the prior written permission of the Legal Department at the Pediatric Stroke Network.

PSN founded by Rachael Hoffman 1999

If you have questions or comments regarding this website, email the webmaster .

 

This page created on 4/29/2002
This page last updated 5/03/2002